The decision may have been made to avoid regulation by the FDA, according to BuzzFeed.
"Advanced biotracking sensors would have made the Apple Watch less of a multipurpose consumer device and more of a medical device used to diagnose diseases or track chronic conditions — which could have opened the watch up to regulation by the U.S. Food and Drug Administration.
'I don’t think Apple wants to be a health-monitoring device maker,' said Harry Wang, director of health and mobile product research at Parks Associates. 'They do want to leverage their popularity on the iPhone as a device platform, integrating all health data that can be collected for different devices.'"
From the article "The Apple Watch Is Scaling Back Its Health Features" by Ian Servantes.
“They have a unique proposition, not just compared with Netflix but also with YouTube TV or Sling,” said Hunter Sappington, an analyst with Parks Associates, in an interview with Deadline. “They have...
Mobile payment apps have gotten off to a slow start and there have been conflicting analyses of their market potential. For instance, customer use of digital wallets stalled in the past year because t...
The vast majority of fitness tracker and smartwatch owners in the United States use their wearables on a daily basis, according to the latest study from Parks Associates. Approximately 68-percent of f...
Earlier this year, a report from digital health analyst Parks Associates found that 27 percent of people with a chronic condition want a mobile health device that tracks their health, but a significan...
